Omapatrilat PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Omapatrilat PowerPoint PPT Presentation
Omapatrilat - Omapatrilat, an octahydropyridothiazepine derivative, has been found to be an ACE inhibitor as well as an endopeptidase inhibitor and was once studied in heart failure and hypertension.
Omapatrilat, an octahydropyridothiazepine derivative, has been found to be an ACE inhibitor as well as an endopeptidase inhibitor and was once studied in heart failure and hypertension.
| PowerPoint PPT presentation | free to download
Omapatrilat in the Treatment of Hypertension PowerPoint PPT Presentation
Omapatrilat in the Treatment of Hypertension - 7asdf. Omapatrilat in the Treatment. of Hypertension. NDA 21-188 ... Patients with increased cardiovascular risk and hypertension that is. difficult to control ...
7asdf. Omapatrilat in the Treatment. of Hypertension. NDA 21-188 ... Patients with increased cardiovascular risk and hypertension that is. difficult to control ...
| PowerPoint PPT presentation | free to view
Basic Sciences and Clinical Implications for Heart Failure Treatment' PowerPoint PPT Presentation
Basic Sciences and Clinical Implications for Heart Failure Treatment' - OVERTURE. Cytokine antagonists. RENAISSANCE. RECOVER. Endothelin antagonists ... OVERTURE: ACE/NEP Inhibitors. in Heart Failure. Omapatrilat. Enalapril. P=0.187 ...
OVERTURE. Cytokine antagonists. RENAISSANCE. RECOVER. Endothelin antagonists ... OVERTURE: ACE/NEP Inhibitors. in Heart Failure. Omapatrilat. Enalapril. P=0.187 ...
| PowerPoint PPT presentation | free to view
IDNT Irbesartan Diabetic Nephropathy Trial PowerPoint PPT Presentation
IDNT Irbesartan Diabetic Nephropathy Trial - Title: IDNT Irbesartan Diabetic Nephropathy Trial Author: marka Last modified by: FDA.CDER Created Date: 4/19/2002 7:07:40 PM Document presentation format
Title: IDNT Irbesartan Diabetic Nephropathy Trial Author: marka Last modified by: FDA.CDER Created Date: 4/19/2002 7:07:40 PM Document presentation format
| PowerPoint PPT presentation | free to view
Chronic therapy of cardiovascular disease PowerPoint PPT Presentation
Chronic therapy of cardiovascular disease - Title: Coaated stents: a new era Subject: theheart.org show Author: Conceptis Technologies Last modified by: sys admin Created Date: 2/9/2001 4:03:24 PM
Title: Coaated stents: a new era Subject: theheart.org show Author: Conceptis Technologies Last modified by: sys admin Created Date: 2/9/2001 4:03:24 PM
| PowerPoint PPT presentation | free to download
OVERTURE PowerPoint PPT Presentation
OVERTURE - OVERTURE. FDA Cardiovascular and Renal Drugs. Advisory Committee Meeting. July 19, 2002 ... (OVERTURE) 52-6. 52-6. 5770 patients with class II, III or IV symptoms ...
OVERTURE. FDA Cardiovascular and Renal Drugs. Advisory Committee Meeting. July 19, 2002 ... (OVERTURE) 52-6. 52-6. 5770 patients with class II, III or IV symptoms ...
| PowerPoint PPT presentation | free to view
Vasoactive peptides PowerPoint PPT Presentation
Vasoactive peptides - Vasoactive peptides By S.Bohlooli, PhD Generation of endothelin-1 (ET-1) in the vascular endothelium, and its direct and indirect effects on smooth muscle cells ...
Vasoactive peptides By S.Bohlooli, PhD Generation of endothelin-1 (ET-1) in the vascular endothelium, and its direct and indirect effects on smooth muscle cells ...
| PowerPoint PPT presentation | free to view
Chronic therapy of cardiovascular disease PowerPoint PPT Presentation
Chronic therapy of cardiovascular disease - Atenolol vs Losartan. 9193 patients. Age 55-80 years. Previously treated or untreated hypertension ... Atenolol 80.9 mm Hg. Losartan 81.3 mm Hg. B Dahlof et al. ...
Atenolol vs Losartan. 9193 patients. Age 55-80 years. Previously treated or untreated hypertension ... Atenolol 80.9 mm Hg. Losartan 81.3 mm Hg. B Dahlof et al. ...
| PowerPoint PPT presentation | free to view
Resistant Hypertension PowerPoint PPT Presentation
Resistant Hypertension - Resistant Hypertension Prof. Dr. Sarma VSN Rachakonda M.D (Internal Medicine)., M.Sc., (Canada), FCGP, FICP, FIMSA, FRCP (G), FCCP (USA), FACP (USA)
Resistant Hypertension Prof. Dr. Sarma VSN Rachakonda M.D (Internal Medicine)., M.Sc., (Canada), FCGP, FICP, FIMSA, FRCP (G), FCCP (USA), FACP (USA)
| PowerPoint PPT presentation | free to download
Congestive Heart Failure PowerPoint PPT Presentation
Congestive Heart Failure - Congestive Heart Failure Dr Ian Coombes Adopted from Duncan McRobbie Principal Clinical Pharmacist (with permission) * Circulating Ang (1-7) levels shown to increase ...
Congestive Heart Failure Dr Ian Coombes Adopted from Duncan McRobbie Principal Clinical Pharmacist (with permission) * Circulating Ang (1-7) levels shown to increase ...
| PowerPoint PPT presentation | free to view
Properties of Drugs PowerPoint PPT Presentation
Properties of Drugs - ... The environment of an atom is specified as follows: C[$(aaO);$(aaaN)] typical datebase queries [s,o]1cccc1 thiophenes and furanes [CX4][NH2] primary ...
... The environment of an atom is specified as follows: C[$(aaO);$(aaaN)] typical datebase queries [s,o]1cccc1 thiophenes and furanes [CX4][NH2] primary ...
| PowerPoint PPT presentation | free to view
Change in Systolic BP at Week 24 for Patients Receiving Adjuncts After Week 8 All Randomized Patient PowerPoint PPT Presentation
Change in Systolic BP at Week 24 for Patients Receiving Adjuncts After Week 8 All Randomized Patient - Change in Systolic BP at Week 24 for Patients Receiving Adjuncts ... p 0.001 vs. lisinopril. Patients uncontrolled with. a regimen not including an ACE-I ...
Change in Systolic BP at Week 24 for Patients Receiving Adjuncts ... p 0.001 vs. lisinopril. Patients uncontrolled with. a regimen not including an ACE-I ...
| PowerPoint PPT presentation | free to view
Cor pulmonale parte II PowerPoint PPT Presentation
Cor pulmonale parte II - Title: Cor pulmonale parte II Author: Dr. Jorge C neva. Buenos Aires.Argentina Last modified by: YYL Created Date: 5/25/1999 10:44:24 PM Document presentation format
Title: Cor pulmonale parte II Author: Dr. Jorge C neva. Buenos Aires.Argentina Last modified by: YYL Created Date: 5/25/1999 10:44:24 PM Document presentation format
| PowerPoint PPT presentation | free to download
Target Identification and Animal Models PowerPoint PPT Presentation
Target Identification and Animal Models - Title: Modern Methods in Drug Discovery Subject: Target Identification and Animal Models Author: Michael Hutter Last modified by: Michael Hutter Created Date
Title: Modern Methods in Drug Discovery Subject: Target Identification and Animal Models Author: Michael Hutter Last modified by: Michael Hutter Created Date
| PowerPoint PPT presentation | free to view
Packer PowerPoint PPT Presentation
Packer
| PowerPoint PPT presentation | free to view
Congestive Heart Failure PowerPoint PPT Presentation
Congestive Heart Failure - Congestive Heart Failure Dr Ian Coombes Adopted from Duncan McRobbie Principal Clinical Pharmacist (with permission) * Circulating Ang (1-7) levels shown to increase ...
Congestive Heart Failure Dr Ian Coombes Adopted from Duncan McRobbie Principal Clinical Pharmacist (with permission) * Circulating Ang (1-7) levels shown to increase ...
| PowerPoint PPT presentation | free to view
Premarketing Risk Assessment Special Conditions PowerPoint PPT Presentation
Premarketing Risk Assessment Special Conditions - Too slow and too fast could both be problems. Risk ... Immunogenicity, neutralizing Abs. For live agents-virulence, transmissibility, genetic stability ...
Too slow and too fast could both be problems. Risk ... Immunogenicity, neutralizing Abs. For live agents-virulence, transmissibility, genetic stability ...
| PowerPoint PPT presentation | free to view
Casos Pr PowerPoint PPT Presentation
Casos Pr - Title: Casos Pr cticos Author: Paula M rquez Last modified by: Paula Created Date: 2/7/2003 9:29:41 AM Document presentation format: Presentaci n en pantalla
Title: Casos Pr cticos Author: Paula M rquez Last modified by: Paula Created Date: 2/7/2003 9:29:41 AM Document presentation format: Presentaci n en pantalla
| PowerPoint PPT presentation | free to view
Angioedema in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial ALLHAT PowerPoint PPT Presentation
Angioedema in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial ALLHAT - Current/past smoker. 6 (75) 2 (67) 27 (73) 4 (80) ... Current smoker, n (%) 14 (37.8) 1981 (21.9) Hx. of diabetes, n (%) 4 (10.8) 3212 (35.5) ...
Current/past smoker. 6 (75) 2 (67) 27 (73) 4 (80) ... Current smoker, n (%) 14 (37.8) 1981 (21.9) Hx. of diabetes, n (%) 4 (10.8) 3212 (35.5) ...
| PowerPoint PPT presentation | free to view
Kering PowerPoint PPT Presentation
Kering - Kering si el gtelens g kezel s nek szempontjai az intenz v ell t st ig nyl betegekben Katona M rta, R cz Katalin, Mader Krisztina,
Kering si el gtelens g kezel s nek szempontjai az intenz v ell t st ig nyl betegekben Katona M rta, R cz Katalin, Mader Krisztina,
| PowerPoint PPT presentation | free to view
The EP Show: New approaches to heart failure PowerPoint PPT Presentation
The EP Show: New approaches to heart failure - The EP Show: New approaches to heart failure. Eric Prystowsky MD ... Cleveland Clinic Foundation. Cleveland, OH. EP Show March 2003. Heart Failure ...
The EP Show: New approaches to heart failure. Eric Prystowsky MD ... Cleveland Clinic Foundation. Cleveland, OH. EP Show March 2003. Heart Failure ...
| PowerPoint PPT presentation | free to view
Jean Rouleau, MD FRCPC PowerPoint PPT Presentation
Jean Rouleau, MD FRCPC - Jean Rouleau, MD FRCPC. Dean of the Faculty of Medicine, ... OVERTURE, 2003. RENAISSANCE, 2002. ENABLE-II, 2001. OPTIMAL, 2003. Vasodilator Hypothesis ...
Jean Rouleau, MD FRCPC. Dean of the Faculty of Medicine, ... OVERTURE, 2003. RENAISSANCE, 2002. ENABLE-II, 2001. OPTIMAL, 2003. Vasodilator Hypothesis ...
| PowerPoint PPT presentation | free to view
Aims PowerPoint PPT Presentation
Aims - To describe the presentation and cellular basis for anaphylaxis ... Non-allergens and hidden allergens. Histamine & the Mast cell ...
To describe the presentation and cellular basis for anaphylaxis ... Non-allergens and hidden allergens. Histamine & the Mast cell ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2025 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
omapatrilat — Search results on PowerShow.com